增强计算机断层扫描(CT)联合一致性超声检查可作为(放)化疗后复发性和持续性颈部转移的充分早期检测工具
这项为期10年的回顾性研究纳入100例初始接受(放)化疗后行颈淋巴结清扫的患者,评估CT与超声检查对残留/复发性颈部淋巴结的检测价值并与组织病理学对比。CT联合超声(n=103)的灵敏度97%、特异度71%、阴性预测值98%、阳性预测值66%、总体准确率81%;对初始接受放化疗者,联合影像的上述指标分别为100.0%、73.5%、100.0%、66.7%和82.7%。结论认为联合使用CT与超声能可靠检测淋巴结转移,尤其在既往接受放化疗的患者中,即使治疗后很长时间。
要点
- CT联合超声检测残留/复发颈部淋巴结的灵敏度97%、特异度71%、阴性预测值98%。
- 初始放化疗者联合影像灵敏度100.0%、特异度73.5%、阴性预测值100.0%。
- 联合影像总体准确率81%,初始放化疗者为82.7%。
核心结论
- 联合使用CT与超声能可靠检测淋巴结转移,尤其在既往接受放化疗的患者中,即使治疗后很长时间。
研究设计与样本
- 为期10年的回顾性研究,纳入100例初始接受(放)化疗后行颈淋巴结清扫的患者。
- 评估CT与超声检查对残留/复发性颈部淋巴结的结果并与组织病理学对比,据此计算灵敏度、特异度、阴性预测值和阳性预测值。
主要发现
- 共分析144份颈淋巴结清扫标本。
- CT联合超声(n=103)的灵敏度97%、特异度71%、阴性预测值98%、阳性预测值66%、总体准确率81%。
- 初始接受放化疗者联合影像的灵敏度100.0%、特异度73.5%、阴性预测值100.0%、阳性预测值66.7%、总体准确率82.7%。
关键数值与推荐
- CT联合超声(n=103):灵敏度97%、特异度71%、阴性预测值98%、阳性预测值66%、总体准确率81%。
- 初始放化疗者联合影像:灵敏度100.0%、特异度73.5%、阴性预测值100.0%、阳性预测值66.7%、总体准确率82.7%。
临床怎么用
- 原文结论认为联合使用CT与超声能可靠检测淋巴结转移,尤其在既往接受放化疗的患者中,即使治疗后很长时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most challenging treatment needs are in recurrent or persisting head and neck squamous cell carcinoma (HNSCC) patients after (((chemo-)radiotherapy) (C)RT). MATERIALS AND METHODS: This 10-year retrospective study included 100 patients, who initially received (C)RT followed by neck dissection (ND). The results of computed tomography (CT) and sonography were evaluated for residual/recurrent cervical lymph nodes and compared to the histopathology. On this basis we calculate the sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV). RESULTS: A total of 144 ND specimens were analyzed. The combination of CT and sonography (n = 103) reached values 97% sensitivity, 71% specificity, 98% NPV, 66% PPV, and 81% overall accuracy. For patients who received as primary treatment CRT the values for the combined imaging were: 100.0%, 73.5%, 100.0%, 66.7% and 82.7% respectively. CONCLUSION: Our study demonstrates that the combined use of CT and sonography reliably detects lymph node metastases, particularly in patients previously treated with CRT, even after a long time after treatment.
引用
- Stöcker C, Greve J, Beer M, et al. Contrast-Enhanced Computed Tomography (CT) With Concordant Sonography as Sufficient Early Detection Tools for Recurrent and Persistent Cervical Metastases After (Chemo)radiotherapy (CRT). Head Neck. 2024. PMID: 39560288. doi:10.1002/hed.28008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。